Evidence map›Paper›PMID 28604695›Full record

ArticleNature chemical biology2017

A scalable platform to identify fungal secondary metabolites and their gene clusters.

Kenneth D Clevenger, Jin Woo Bok, Rosa Ye, Galen P Miley, Maria H Verdan, Thomas Velk, Cynthia Chen, KaHoua Yang, Matthew T Robey, Peng Gao and 7 more

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 189 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Draft genome ofMicrobiology resource announcements · 2025
    Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Kenneth D ClevengerDepartment of Chemistry, Northwestern University, Evanston, Illinois, USA.
Jin Woo BokDepartment of Medical Microbiology and Immunology and Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Rosa YeIntact Genomics, Inc., St. Louis, Missouri, USA.
Galen P MileyDepartment of Chemistry, Northwestern University, Evanston, Illinois, USA.
Maria H VerdanDepartment of Chemistry, Northwestern University, Evanston, Illinois, USA.ORCID http://orcid.org/0000-0002-2460-0372
Thomas VelkDepartment of Medical Microbiology and Immunology and Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Cynthia ChenIntact Genomics, Inc., St. Louis, Missouri, USA.
KaHoua YangDepartment of Medical Microbiology and Immunology and Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Matthew T RobeyDepartment of Molecular Biosciences, Northwestern University, Evanston, Illinois, USA.
Peng GaoProteomics Center of Excellence, Northwestern University, Evanston, Illinois, USA.
Matthew LamprechtIntact Genomics, Inc., St. Louis, Missouri, USA.
Paul M ThomasProteomics Center of Excellence, Northwestern University, Evanston, Illinois, USA.ORCID http://orcid.org/0000-0003-2887-4765
Md Nurul IslamIntact Genomics, Inc., St. Louis, Missouri, USA.
Jonathan M PalmerCenter for Forest Mycology Research, Northern Research Station, US Forest Service, Madison, Wisconsin, USA.ORCID http://orcid.org/0000-0003-0929-3658
Chengcang C WuIntact Genomics, Inc., St. Louis, Missouri, USA.
Nancy P KellerDepartment of Medical Microbiology and Immunology and Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Neil L KelleherDepartment of Chemistry, Northwestern University, Evanston, Illinois, USA.ORCID http://orcid.org/0000-0002-8815-3372
Northwestern University · USIntact Genomics (United States) · USUniversity of Wisconsin–Madison · USUS Forest Service · US

Funding

Developing Capacity to Evaluate Training Programs via Development of Human, Institutional and Social CapitalT32GM008449 · NIGMS · NORTHWESTERN UNIVERSITY · PI LEONARD, JOSHUA NATHANIEL · 1993 to 2023
$7.8M
Mass Spectrometric Studies of Thiotemplate BiosynthesisR01AT009143 · NCCIH · NORTHWESTERN UNIVERSITY · PI NEIL L KELLEHER, NANCY P KELLER · 2016 to 2026
$4.2M
Mechanisms of an Aspergillus fumigatus virulence mutantR01AI065728 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KELLER, NANCY P · 2006 to 2017
$3.6M
Chemistry of Life Processes Predoctoral Training ProgramT32GM105538 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2013 to 2022
$2.7M
Expanding small molecule functional metagenomics through shuttle BAC expression iR44AI094885 · NIAID · INTACT GENOMICS, INC. · PI BOK, JIN WOO, KELLEHER, NEIL L · 2014 to 2015
$1.8M
A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulansR43AT009158 · NCCIH · INTACT GENOMICS, INC. · PI WU, CHENGCANG CHARLES · 2016 to 2016
$225k
Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics DiscoveryR43AI118086 · NIAID · INTACT GENOMICS, INC. · PI KELLER, NANCY P, WU, CHENGCANG CHARLES · 2015 to 2015
$211k
Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil MetagenoR43AI085840 · NIAID · LUCIGEN CORPORATION · PI WU, CHENGCANG CHARLES · 2010 to 2010
$165k
NCCIH NIH HHS R01 AT009143NCCIH NIH HHS R43 AT009158NIAID NIH HHS R01 AI065728NIAID NIH HHS R43 AI085840NIAID NIH HHS R43 AI118086NIAID NIH HHS R44 AI094885NIGMS NIH HHS T32 GM008449NIGMS NIH HHS T32 GM105538
6 · The paper itself

Abstract

The genomes of filamentous fungi contain up to 90 biosynthetic gene clusters (BGCs) encoding diverse secondary metabolites-an enormous reservoir of untapped chemical potential. However, the recalcitrant genetics, cryptic expression, and unculturability of these fungi prevent scientists from systematically exploiting these gene clusters and harvesting their products. As heterologous expression of fungal BGCs is largely limited to the expression of single or partial clusters, we established a scalable process for the expression of large numbers of full-length gene clusters, called FAC-MS. Using fungal artificial chromosomes (FACs) and metabolomic scoring (MS), we screened 56 secondary metabolite BGCs from diverse fungal species for expression in Aspergillus nidulans. We discovered 15 new metabolites and assigned them with confidence to their BGCs. Using the FAC-MS platform, we extensively characterized a new macrolactone, valactamide A, and its hybrid nonribosomal peptide synthetase-polyketide synthase (NRPS-PKS). The ability to regularize access to fungal secondary metabolites at an unprecedented scale stands to revitalize drug discovery platforms with renewable sources of natural products.

Indexed as

Multigene FamilyAspergillusBenzodiazepinesGenes, FungalPyrimidinonesSecondary MetabolismSesterterpenesBenzodiazepinesbenzomalvin Abenzomalvin BPyrimidinonesSesterterpenes

Identifiers

PMID28604695
PMCPMC5577364
OpenAlexW2626832796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.